ArticleScientific reports2026
In vitro adventitious root culture of Withania somnifera L.: a strategy for enhanced secondary metabolite production with therapeutic antioxidant and anti-inflammatory potential.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nutraceutical Applications ofFoods (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The adventitious root culture is an effective in vitro technique for producing valuable secondary metabolites. These cultures operate independently of the shoots and quickly provide a substantial raw material. This study is the first report aimed at reducing the cost of biomass production by encouraging adventitious root development and examining the potential of secondary metabolites produced from adventitious root cultures of Withania somnifera L. to kill cancer cells (Hep-G2) and reduce in vitro inflammation activity by testing their ability to prevent lipoxygenase and proteinase from performing their activities. IBA concentrations were tested to induce adventitious roots from W. somnifera L. plantlet leaves; the optimal IBA concentration was 1.0 mg/L. In addition, increasing the number of subcultures led to an increase in biomass to 5.84-fold in the fifth subculture. The macronutrient content, antioxidant tests, flavonoids, phenolic, and HPLC analysis were assessed. Anticancer and anti-inflammatory characteristics were evaluated. The results of total phenolics and total flavonoids were 27.42 ± 2.57 and 7.21 ± 0.14 mg/g Dw, respectively, and total antioxidant activities, including DPPH and ABTS, were 13.61 ± 2.21 and 18.31 ± 1.34 mg/g Dw, respectively. HPLC analysis revealed that catechin and gallic acid were the highest compounds, with concentrations of 419.26 and 249.73 µg/g, respectively, which correlated with strong anti-inflammatory and cytotoxic activities in vitro. Moreover, the IC50 for cytotoxicity against Hep-G2 was 100 µg/ml. In conclusion, the in vitro W. somnifera L. adventitious roots have shown promising results in the synthesis of secondary metabolites. Moreover, these adventitious roots have significant nutritional value, which increases antioxidant activity, in addition to their potential application as new natural secondary metabolites.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.